Form 8-K - Current report:
SEC Accession No. 0001193125-22-298049
Filing Date
2022-12-05
Accepted
2022-12-05 08:39:06
Documents
15
Period of Report
2022-11-30
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d418516d8k.htm   iXBRL 8-K 33794
2 EX-99.1 d418516dex991.htm EX-99.1 7743
7 GRAPHIC g418516g1203075031757.jpg GRAPHIC 2692
  Complete submission text file 0001193125-22-298049.txt   209748

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA zyme-20221130.xsd EX-101.SCH 3541
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE zyme-20221130_def.xml EX-101.DEF 14162
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE zyme-20221130_lab.xml EX-101.LAB 23362
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE zyme-20221130_pre.xml EX-101.PRE 15052
9 EXTRACTED XBRL INSTANCE DOCUMENT d418516d8k_htm.xml XML 5449
Mailing Address 108 PATRIOT DRIVE, SUITE A MIDDLETOWN DE 19709
Business Address 108 PATRIOT DRIVE, SUITE A MIDDLETOWN DE 19709 206-337-1030
Zymeworks Inc. (Filer) CIK: 0001937653 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41535 | Film No.: 221443838
SIC: 2834 Pharmaceutical Preparations